Drug Type ASO |
Synonyms NCNP-04, NS 051 |
Target |
Mechanism DMD exon 51 modulators(Dystrophin exon 51 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | US | 12 Sep 2023 |